Wealthcare Capital Partners’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$411K Buy
2,802
+668
+31% +$97.2K 0.17% 111
2026
Q1
$308K Sell
2,134
-855
-29% -$130K 0.14% 117
2025
Q4
$428K Buy
2,989
+219
+8% +$32.3K 0.2% 95
2025
Q3
$426K Sell
2,770
-1,053
-28% -$164K 0.2% 96
2025
Q2
$609K Sell
3,823
-100
-3% -$16.3K 0.31% 57
2025
Q1
$669K Sell
3,923
-43
-1% -$7.2K 0.34% 48
2024
Q4
$665K Buy
+3,966
New +$675K 0.35% 44

Other funds holding PG

Wealthcare Capital Partners's PG Position: Q2 2026 in Review

Wealthcare Capital Partners increased its Procter & Gamble (PG) stake by 31% in Q2 2026, buying an estimated $97.2K and bringing the position to 2,802 shares worth $411K. The position accounts for 0.17% of the portfolio, ranked #111.

Wealthcare Capital Partners first reported a position in PG in Q4 2024 and has held it in 7 quarters since. The position peaked at $669K in Q1 2025. 1,982 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Wealthcare Capital Partners held 2,802 shares of Procter & Gamble worth $411K as of Q2 2026.
  • Wealthcare Capital Partners bought 668 Procter & Gamble shares in Q2 2026, an estimated $97.2K.
  • Procter & Gamble made up 0.17% of Wealthcare Capital Partners's portfolio in Q2 2026, its #111 holding.
  • Wealthcare Capital Partners first reported a position in Procter & Gamble in Q4 2024 and has held it in 7 quarters since.
  • Wealthcare Capital Partners's Procter & Gamble position peaked at $669K in Q1 2025.
  • 1,982 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Wealthcare Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.